Hortal Javier, Muñoz Patricia, Cuerpo Gregorio, Litvan Hector, Rosseel Peter M, Bouza Emilio
Anaesthesia Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Crit Care. 2009;13(3):R80. doi: 10.1186/cc7896. Epub 2009 May 22.
Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our aim was to determine the incidence, aetiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients who have undergone MHS in Europe.
Our study was a prospective study of patients undergoing MHS in Europe who developed suspicion of VAP. During a one-month period, participating units submitted a protocol of all patients admitted to their units who had undergone MHS.
Overall, 25 hospitals in eight different European countries participated in the study. The number of patients intervened for MHS was 986. Fifteen patients were excluded because of protocol violations. One or more nosocomial infections were detected in 43 (4.4%) patients. VAP was the most frequent nosocomial infection (2.1%; 13.9 episodes per 1000 days of mechanical ventilation). The microorganisms responsible for VAP in this study were: Enterobacteriaceae (45%), Pseudomonas aeruginosa (20%), methicillin-resistant Staphylococcus aureus (10%) and a range of other microorganisms. We identified the following significant independent risk factors for VAP: ascending aorta surgery (odds ratio (OR) = 6.22; 95% confidence interval (CI) = 1.69 to 22.89), number of blood units transfused (OR = 1.08 per unit transfused; 95% CI = 1.04 to 1.13) and need for re-intervention (OR = 6.65; 95% CI = 2.10 to 21.01). The median length of stay in the intensive care unit was significantly longer (P < 0.001) in patients with VAP than in patients without VAP (23 days versus 2 days). Death was significantly more frequent (P < 0.001) in patients with VAP (35% versus 2.3%).
Patients undergoing aortic surgery and those with complicated post-intervention courses, requiring multiple transfusions or re-intervention, constitute a high-risk group probably requiring more active preventive measures.
接受心脏大手术(MHS)的患者是医院感染风险的特殊亚群。术后感染是MHS后主要的非心脏并发症,且与发病率增加、医院资源使用及死亡率明显相关。我们的目的是确定欧洲接受MHS患者中呼吸机相关性肺炎(VAP)的发病率、病因、危险因素及结局。
我们的研究是对欧洲接受MHS且疑似发生VAP的患者进行的前瞻性研究。在一个月的时间里,参与单位提交了其单位内所有接受MHS患者的方案。
总体而言,来自八个不同欧洲国家的25家医院参与了该研究。接受MHS干预的患者有986例。15例患者因违反方案被排除。43例(4.4%)患者检测到一种或多种医院感染。VAP是最常见的医院感染(2.1%;每1000天机械通气发生13.9例)。本研究中导致VAP的微生物有:肠杆菌科(45%)、铜绿假单胞菌(20%)、耐甲氧西林金黄色葡萄球菌(10%)及一系列其他微生物。我们确定了以下VAP的显著独立危险因素:升主动脉手术(比值比(OR)=6.22;95%置信区间(CI)=1.69至22.89)、输血单位数(每输注一个单位OR=1.08;95%CI=1.04至1.13)及再次干预需求(OR=6.65;95%CI=2.10至21.01)。VAP患者在重症监护病房的中位住院时间显著长于无VAP患者(23天对2天,P<0.001)。VAP患者的死亡频率显著更高(35%对2.3%,P<0.001)。
接受主动脉手术的患者以及干预后病程复杂、需要多次输血或再次干预的患者构成高危组群,可能需要更积极的预防措施。